Hillstream BioPharma, Inc. (HILS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 8, 2022, reports on the results of the 2022 Annual Meeting of Stockholders held by Hillstream BioPharma, Inc. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC under the symbol HILS. The filing is an emerging growth company report.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 8,961,480 shares were represented at the meeting, constituting a quorum. The following matters were submitted to a vote:
- Proposal 1: Election of Directors
- Four nominees were elected to serve until the next annual meeting or until their successors are qualified.
- Randy Milby: 8,109,684 For, 0 Against, 24,255 Abstain, 827,541 Broker Non-Votes.
- Leonard Mazur: 8,109,674 For, 0 Against, 24,265 Abstain, 827,541 Broker Non-Votes.
- Lynne A. Bui: 8,112,688 For, 0 Against, 21,251 Abstain, 827,541 Broker Non-Votes.
- Sireesh Appajosyula: 8,112,674 For, 0 Against, 21,265 Abstain, 827,541 Broker Non-Votes.
- Proposal 2: Ratification of Independent Auditors
- Stockholders approved the appointment of Mayer Hoffman McCann P.C. (MHM) as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
- Vote Results: 8,938,560 For, 8,442 Against, 14,478 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The report is limited to the disclosure of voting outcomes.
Key Facts for Investor Verification
- Verify the continued tenure of the four elected directors: Randy Milby, Leonard Mazur, Lynne A. Bui, and Sireesh Appajosyula.
- Confirm that Mayer Hoffman McCann P.C. is the appointed auditor for the fiscal year ending December 31, 2022.
- Note the significant number of broker non-votes (827,541) regarding the director elections, which indicates shares held by brokers that were not voted on these matters.
- Review the Definitive Proxy Statement filed on June 17, 2022, for detailed background on the proposals.